The EU Medical Device Regulation 2017/745 (MDR) represents one of the most significant regulatory shifts the MedTech industry has ever faced. Introduced to strengthen patient safety, clinical evidence, and post-market oversight, the MDR has raised the bar for bringing medical devices to the European market and for keeping them there. For startups, scale-ups, and SMEs, the regulation can feel complex, resource-intensive, and difficult to interpret, particularly when guidance continues to evolve. And this is for good reason, because the MDR is complex, resource-intensive, and difficult to interpret! Without the right strategy and expertise, MDR compliance can quickly become a significant barrier to innovation, investment, and commercial growth.
Whether you are preparing for your first CE mark, transitioning legacy devices from the MDD, or expanding your product portfolio under the MDR, MD Compliance can help you navigate the Regulation efficiently, proportionately, and with confidence.
We pride ourselves on being pragmatic and commercially aware. We understand that startups and growing companies don’t have unlimited time or regulatory resources, so we tailor our support to your business objectives, risk profile, and internal capabilities. Rather than overwhelming you with theoretical interpretations of the MDR, we focus on clear decision-making, defensible documentation, and strategies that stand up to scrutiny while keeping projects moving forward.
Correct classification and a robust regulatory strategy are the foundation of successful MDR compliance. We support you in determining the appropriate MDR classification for your device, including borderline and complex cases where interpretation is not straightforward. Our team evaluates your intended purpose, technology, claims, and risk profile to ensure classification decisions are well-justified and aligned with current guidance and Notified Body expectations.
Beyond classification, we develop end-to-end MDR regulatory strategies that align compliance activities with your development and commercial timelines. This includes defining applicable conformity assessment routes, identifying clinical evidence requirements, planning legacy device transitions, and advising on post-market surveillance and vigilance obligations. For startups and scale-ups, we also help ensure that regulatory strategy supports funding milestones, partnerships, and market entry plans — not just compliance in isolation.
The MDR places significantly greater emphasis on the quality, depth, and structure of technical documentation. We support clients with the compilation of complete, MDR-compliant technical files and design dossiers, ensuring all required elements are present, consistent, and clearly presented for easy navigation and review by your Notified Body.
For companies transitioning from the MDD, we can conduct efficient, comprehensive gap assessments against MDR requirements and provide clear remediation plans to address deficiencies. This includes updates to General Safety and Performance Requirements (GSPR) mapping, clinical evaluation documentation, risk management files, usability engineering, and post-market surveillance plans. We also support the integration of clinical data, literature reviews, and post-market evidence into a coherent and defensible technical narrative.
Our approach is collaborative and our consultants cover a wide range of technical expertise, always taking into account the current state of the art. We often lead documentation development end-to-end, but we are also comfortable working alongside your internal teams to upskill them, review existing content, and provide targeted expertise where it is most needed. The result is documentation that is not only MDR-compliant, but structured to withstand detailed assessment and future changes.
Securing and working effectively with a Notified Body is one of the biggest challenges under the MDR. Capacity constraints, different scope codes, varying interpretations, and long review timelines can introduce significant risk to project plans if not managed carefully. We support you throughout the full Notified Body journey — from selection through to certification and beyond.
Our team helps identify and shortlist suitable Notified Bodies based on your device type, classification, and business priorities. We support preparation of applications, technical documentation submissions, and responses to Notified Body questions and non-conformities. During assessments, we act as a knowledgeable interface, helping you interpret feedback, manage timelines, and maintain momentum.
In addition to MDR regulatory consulting, MD Compliance supports manufacturers through Stage 1 and Stage 2 ISO 13485 audits, recognising the critical role a compliant quality management system plays in achieving and maintaining MDR certification. We help organisations prepare for audit readiness through targeted gap assessments, documentation review, and practical coaching, ensuring quality systems are both compliant and effectively implemented. During Stage 1 and Stage 2 audits, we support clients in addressing auditor feedback, responding to non-conformities, and maintaining momentum toward certification. Our experienced consultants bring first-hand knowledge of auditor expectations, helping reduce audit risk and support a smoother path to MDR conformity.
